Kerecis Unveils 1st European Center of Excellence for Fish-Skin Tech

Kerecis, pioneer of using fish skin and fatty acids for tissue regeneration and protection, has designated its first European Center of Excellence: the Chirurgische Praxisklinik am Friedensengel in Munich, Germany.

Kerecis’ Centers of Excellence are meant to be hubs for peer-to-peer mentoring, advanced training, and collaborative research into applications of its fish skin technology. The company said these centers encourage sharing of best practices and offer expert guidance.

This new facility extend the company’s Center of Excellence program outside the U.S. for the first time.

The Chirurgische Praxisklinik am Friedensengel, an outpatient clinic for general surgery and traumatology, is led by Dr. Sandra Moritz, a general surgeon specializing in natural and biological treatment methods. Dr. Moritz has been an advocate of Kerecis fish-skin technology for more than six years, using the fish-skin to treat severe wounds and tissue damage where the standard of care fails to provide adequate outcomes.

As an early adopter of Kerecis technology, Dr. Moritz frequently shares her expertise at medical conferences and events worldwide.

“I cannot imagine running my practice without Kerecis fish-skin, I use it on a variety of conditions daily. I am extremely grateful for this treatment option for my patients,” said Dr. Moritz.

“This recognition of Chirurgische Praxisklinik am Friedensengel as our first European Center of Excellence underscores Kerecis’ growing presence and recognition in Germany,” said Fertram Sigurjonsson, Founder and CEO of Kerecis. “Dr. Moritz and her team exemplify the innovation, expertise, and dedication that drive advancements in tissue regeneration.”

Kerecis was acquired by Coloplast last year in a $1.3 billion deal. In July 2024, Kerecis released Shield Spinal, a fish-skin graft and silicone combination with perforated fenestration marks cut in a spiral pattern to facilitate customization.